AMNIS Treasury Services AG secures CHF 10m in Series B financing round to strengthen AMNIS’ position in existing markets and to accelerate expansion
Niederer Kraft Frey advised AMNIS on its CHF 10 million series B financing round lead by Swisscom Ventures.
AB2 Bio signs option and licensing agreement with Nippon Shinyaku
Niederer Kraft Frey advised AB2 Bio Ltd, a Lausanne, Switzerland based biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18,
Transgourmet Ibérica acquires Moyà Saus
Niederer Kraft Frey advised Transgourmet Ibérica, a benchmark in hospitality distribution and supermarkets,
NKF strengthens its tax practice with the appointment of one new partner and two new counsels
Niederer Kraft Frey is pleased to announce the appointment of Morgan Boëffard as partner, effective 1 January 2025.
Swiss Prime Site raises CHF 300m by way of an accelerated bookbuilding
Swiss Prime Site (SIX: SPSN) has successfully placed 2,926,829 newly issued shares by way of an accelerated bookbuild offering.
EFG acquires Swiss private bank Cité Gestion
Niederer Kraft Frey is acting as counsel to EFG International in the acquisition of 100 percent of the Swiss private bank Cité Gestion announced on 19 February 2025.
Shift4 to acquire Global Blue
Niederer Kraft Frey is representing Global Blue (NYSE: GB), the leading specialty payments and technology platform enabling tax-free shopping,
HBX Group successfully goes public on the Spanish Stock Exchange
Niederer Kraft Frey advised EQT on a complex pre-IPO reorganisation of HBX group’s corporate structure and the IPO of its portfolio company HBX Group (formerly Hotelbeds).
Largo Films SA completes Series A financing round
Niederer Kraft Frey acted as Swiss counsel to LARGO FILMS SA in its Series A financing round, co-led by Los Angeles-based TI Capital Management LLC and QBIT Global Ventures Fund I LP.
Institut für histologische und zytologische Diagnostik AG Aarau acquired by Affidea Group
Niederer Kraft Frey advised the shareholders of Institut für histologische und zytologische Diagnostik AG Aarau (IHZD) on the sale of IHZD to Affidea Group.